Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 47Carcinoma, Hepatocellular 30Neoplasms 18Neoplasm Metastasis 14Melanoma 14Stomach Neoplasms 13Esophageal Neoplasms 13Colorectal Neoplasms 12Nasopharyngeal Carcinoma 11Esophageal Squamous Cell Carcinoma 10Triple Negative Breast Neoplasms 9Head and Neck Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Recurrence 8Breast Neoplasms 8Rectal Neoplasms 7Pancreatic Neoplasms 7Lung Neoplasms 7Carcinoma, Renal Cell 7Biliary Tract Neoplasms 7Small Cell Lung Carcinoma 6Cholangiocarcinoma 6Liver Neoplasms 5Colonic Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Locally Advanced Rectal Cancer 4Advanced NSCLC 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3

Interventions

Surveys and Questionnaires 2bemarituzumab 1Radiotherapy 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Lapatinib 1Irinotecan 1Immune Checkpoint Inhibitors 1Fluorouracil 1Exercise 1Diet Therapy 1Carboplatin 1Capecitabine 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
GastroEsophageal Cancer × Immune Checkpoint Inhibitors × Clear all
NCT06283238 2026-01-29

Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

Duke University

Withdrawn
Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡